These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9001844)

  • 1. Practical issues in conducting pharmacoeconomic studies.
    Rajagopalan R; Kallal JE; Fowler JF; Sherertz EF
    Clin Ther; 1996; 18(6):1298-306. PubMed ID: 9001844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An economic evaluation of patch testing in the diagnosis and management of allergic contact dermatitis.
    Rajagopalan R; Anderson RT; Sarma S; Kallal J; Retchin C; Jones J; Fowler JF; Sherertz EF
    Am J Contact Dermat; 1998 Sep; 9(3):149-54. PubMed ID: 9744907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of decision-analytical modelling in economic evaluation of patch testing in allergic contact dermatitis.
    Rajagopalan R; Anderson RT; Sarma S; Retchin C; Jones J
    Pharmacoeconomics; 1998 Jul; 14(1):79-95. PubMed ID: 10182197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of patch testing on dermatology-specific quality of life in patients with allergic contact dermatitis.
    Rajagopalan R; Anderson R
    Am J Contact Dermat; 1997 Dec; 8(4):215-21. PubMed ID: 9417366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human and economic impact of allergic contact dermatitis and the role of patch testing.
    Rietschel RL
    J Am Acad Dermatol; 1995 Nov; 33(5 Pt 1):812-5. PubMed ID: 7593782
    [No Abstract]   [Full Text] [Related]  

  • 6. A retrospective evaluation of patch testing in patients diagnosed with allergic contact dermatitis.
    Rajagopalan R; Kallal JE; Fowler JF; Sherertz EF
    Cutis; 1996 May; 57(5):360-4. PubMed ID: 8726721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacoeconomics.
    Ahuja J; Gupta M; Gupta AK; Kohli K
    Natl Med J India; 2004; 17(2):80-3. PubMed ID: 15141600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reimbursement for patch testing at academic centers: the Achilles' heel of academic contact dermatitis specialists.
    Warshaw EM
    Am J Contact Dermat; 2003 Dec; 14(4):215-6. PubMed ID: 14738724
    [No Abstract]   [Full Text] [Related]  

  • 9. Protocol-driven costs in trial-based pharmacoeconomic analyses.
    Gandjour A
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):673-5. PubMed ID: 22098282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacoeconomic research and clinical trials: concepts and issues.
    Bootman JL; Larson LN; McGhan WF; Townsend RJ
    DICP; 1989 Sep; 23(9):693-7. PubMed ID: 2800585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Practical Guide to Patch Testing.
    Fonacier L
    J Allergy Clin Immunol Pract; 2015; 3(5):669-75. PubMed ID: 26054552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of Patch Test Business Models in the United States by the American Contact Dermatitis Society.
    Zhu TH; Suresh R; Farahnik B; Jeon C; Warshaw E; Scheinman P; Mowad C; Botto N; Brod B; Taylor JS; Atwater AR; Watsky K; Schalock PC; Machler BC; Helms S; Jacob SE; Murase JE
    Dermatitis; 2018; 29(2):85-88. PubMed ID: 29494395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concept of Combining Cost-Effectiveness Analysis and Budget Impact Analysis in Health Care Decision-Making.
    Yagudina RI; Kulikov AU; Serpik VG; Ugrekhelidze DT
    Value Health Reg Issues; 2017 Sep; 13():61-66. PubMed ID: 29073991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report.
    Ramsey S; Willke R; Briggs A; Brown R; Buxton M; Chawla A; Cook J; Glick H; Liljas B; Petitti D; Reed S
    Value Health; 2005; 8(5):521-33. PubMed ID: 16176491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing value through pharmacoeconomics: the emerging third objective in clinical trials.
    Boyer JG; Pathak DS
    Top Hosp Pharm Manage; 1994 Jan; 13(4):1-10. PubMed ID: 10130679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacoeconomic concepts in antiplatelet therapy: understanding cost-effectiveness analyses using clopidogrel as an example.
    Weintraub WS
    J Cardiovasc Pharmacol Ther; 2008 Jun; 13(2):107-19. PubMed ID: 18495905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intradermal testing in the diagnosis of allergic contact dermatitis. A reappraisal.
    Herbst RA; Lauerma AI; Maibach HI
    Contact Dermatitis; 1993 Jul; 29(1):1-5. PubMed ID: 8365145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muted incentives, omitted variables, and pharmacoeconomic validity: two strikes and you're out!
    Callahan J; Lyles A; Molinari C
    Clin Ther; 2011 Jan; 33(1):60-1. PubMed ID: 21397774
    [No Abstract]   [Full Text] [Related]  

  • 20. EAACI position paper for practical patch testing in allergic contact dermatitis in children.
    de Waard-van der Spek FB; Darsow U; Mortz CG; Orton D; Worm M; Muraro A; Schmid-Grendelmeier P; Grimalt R; Spiewak R; Rudzeviciene O; Flohr C; Halken S; Fiocchi A; Borrego LM; Oranje AP
    Pediatr Allergy Immunol; 2015 Nov; 26(7):598-606. PubMed ID: 26287570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.